Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Nexalin Technology, Inc. (NXL : NSDQ)

• Company Description    Nexalin Technology Inc. designs and develops neurostimulation products for mental health epidemic. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. Nexalin Technology Inc. is based in Houston, Texas. Number of Employees: 8

• Price / Volume Information    Yesterday's Closing Price: $0.36 Daily Weekly Monthly 20 Day Moving Average: 124,031 shares Shares Outstanding: 20.58 (millions) Market Capitalization: $7.50 (millions) Beta: 4.05 52 Week High: $2.31 52 Week Low: $0.36 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -22.51% -16.31% 12 Week -37.49% -32.68% Year To Date -34.73% -29.85%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1776 YORKTOWN SUITE 550 - Houston,TX 77056 USA ph: 832-260-0222 fax: - nxl@crescendo-ir.com http://www.nexalin.com

• General Corporate Information    Officers Mark White - Chief Executive Officer Justin Van Fleet - Chief Financial Officer Leslie Bernhard - Director Alan Kazden - Director David Owens - Director Peer Information Nexalin Technology, Inc. (EVOL) Nexalin Technology, Inc. (RAMP) Nexalin Technology, Inc. (LGTY) Nexalin Technology, Inc. (ALOT) Nexalin Technology, Inc. (CXT) Nexalin Technology, Inc. (TGHI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Technology Services Sector: Business Services CUSIP: 65345B201 SIC: 3845 Fiscal Year Fiscal Year End: December Last Reported Quarter: 12/01/25 Next Expected EPS Date: 05/12/26 Share - Related Items Shares Outstanding: 20.58 Most Recent Split Date: (:1) Beta: 4.05 Market Capitalization: $7.50 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 05/12/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.00 Price/Cash Flow: - Price / Sales: 24.82 EPS Growth vs. Year Ago Period: 53.57% vs. Previous Quarter: 0.00% Sales Growth vs. Year Ago Period: 537.04% vs. Previous Quarter: 855.56% ROE 12/31/25 - -0.87 09/30/25 - -0.94 06/30/25 - -0.96 ROA 12/31/25 - -0.71 09/30/25 - -0.82 06/30/25 - -0.84 Current Ratio 12/31/25 - 4.85 09/30/25 - 13.45 06/30/25 - 10.43 Quick Ratio 12/31/25 - 4.70 09/30/25 - 13.01 06/30/25 - 10.14 Operating Margin 12/31/25 - -2,722.19 09/30/25 - -5,527.39 06/30/25 - -5,057.14 Net Margin 12/31/25 - -2,722.19 09/30/25 - -5,527.39 06/30/25 - -5,057.14 Pre-Tax Margin 12/31/25 - -2,722.19 09/30/25 - -5,527.39 06/30/25 - -5,057.14 Book Value 12/31/25 - 200.94 09/30/25 - 0.27 06/30/25 - 0.35 Inventory Turnover 12/31/25 - 0.00 09/30/25 - 0.00 06/30/25 - 0.00 Debt-to-Equity 12/31/25 - 0.00 09/30/25 - 0.00 06/30/25 - 0.00 Debt-to-Capital 12/31/25 - 0.00 09/30/25 - 0.00 06/30/25 - 0.00

Powered by Zacks Investment Research ©